WS Data Solutions
Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Sell
Standard Deviation
Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Annexon, Inc. Common Stock (ANNX)
Pharmaceutical Preparations
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexon's product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases.
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200
BRISBANE, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/24/2020
Market Cap
633,924,000
Shares Outstanding
78,340,000
Weighted SO
78,273,985
Total Employees
N/A
Upcoming Earnings
08/05/2024
Beta
1.2910
Last Div
0.0000
Range
1.57-8.4
Chg
0.0200
Avg Vol
2723151
Mkt Cap
633924000
Exch
NASDAQ
Country
US
Phone
650 822 5500
DCF Diff
3.4196
DCF
2.5604
Div Yield
0.0000
P/S
130.2762
EV Multiple
-4.0464
P/FV
2.1624
Div Yield %
0.0000
P/E
-6.7802
PEG
-0.2257
Payout
0.0000
Current Ratio
21.8083
Quick Ratio
21.8083
Cash Ratio
9.1733
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
448.3447
CCC
-448.3447
Gross Margin
0.3097
Op Margin
-26.0875
Pretax Margin
-23.6661
Net Margin
-23.6661
Eff Tax Rate
-0.0196
ROA
-0.2836
ROE
-0.4468
ROCE
-0.3264
NI/EBT
1.0000
EBT/EBIT
0.9072
EBIT/Rev
-26.0875
Debt Ratio
0.0744
D/E
0.0836
LT Debt/Cap
0.0716
Total Debt/Cap
0.0772
Int Coverage
-40.9226
CF/Debt
-3.3687
Equity Multi
1.1246
Rec Turnover
0.0000
Pay Turnover
0.8141
Inv Turnover
0.0000
FA Turnover
0.1565
Asset Turnover
0.0120
OCF/Share
-0.7818
FCF/Share
-0.7820
Cash/Share
2.8332
OCF/Sales
-20.9092
FCF/OCF
1.0003
CF Coverage
-3.3687
ST Coverage
-43.3876
CapEx Coverage
-3913.2308
Div&CapEx Cov
-3913.2308
P/BV
2.1624
P/B
2.1624
P/S
130.2762
P/E
-6.7802
P/FCF
-6.2290
P/OCF
-7.6741
P/CF
-7.6741
PEG
-0.2257
P/S
130.2762
EV Multiple
-4.0464
P/FV
2.1624
DPS
0.0000